Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | ALB | P02768 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30435544 | 0.78 | TRPV4 (0.46) | TRPV4MEN1TTRALBKMT2A | |
| SCHEMBL17188083 | 0.75 | KDM4E (0.33) | TRPV4MEN1KMT2AKDM4EHPGD | |
| SCHEMBL1727262 | 0.74 | TRPV4 (0.41) | TRPV4MEN1TTRALBKMT2A | |
| SCHEMBL15406588 | 0.74 | TTR (0.58) | TRPV4MEN1TTRALBKMT2A | |
| SCHEMBL29017429 | 0.73 | TRPV4 (0.42) | TRPV4HTT | |
| SCHEMBL29450561 | 0.73 | TRPV4 (0.37) | TRPV4KDM4EHPGD | |
| SCHEMBL2729265 | 0.73 | TRPV4 (0.37) | TRPV4KDM4EHPGD | |
| SCHEMBL9625848 | 0.73 | TRPV4 (0.41) | TRPV4MEN1KMT2AHPGD | |
| SCHEMBL57543 | 0.73 | TRPV4 (0.41) | TRPV4MEN1KMT2AHPGD | |
| SCHEMBL3474652 | 0.72 | TRPV4 (0.33) | TRPV4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11453682-B2 | Condensed-cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-09-27 | — | — | US | disclosed |
| US-20200317694-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200317694-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, CCNA1 | TRPV4 2065/4885MEN1 141/4885TTR 3273/4885 |
| US-11453682-B2 | Condensed-cyclic compound and organic light-emitting device including the same | CRY1, CCNT1, CCNA1 | TRPV4 2065/4885MEN1 141/4885TTR 3273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.